Former Purdue Pharma L.P. Execs Lose Federal Appeal
Published: Jul 30, 2012
A federal appeals court upheld HHS' decision to exclude three former Purdue Pharma executives from participating in federal healthcare programs such as Medicare and Medicaid. Michael Friedman, Paul Goldenheim and Howard Udell, executives of what was then called Purdue Frederick, pleaded guilty in 2007 for failing to prevent the company's fraudulent marketing of the painkiller OxyContin. In its opinion (PDF), the U.S. Court of Appeals for the District of Columbia Circuit Court ruled that the executives can be excluded from federal healthcare programs for their misdemeanor misbranding convictions.